Akoya Biosciences (AKYA)
(Delayed Data from NSDQ)
$3.80 USD
-0.02 (-0.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
AKYA 3.80 -0.02(-0.52%)
Will AKYA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AKYA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AKYA
Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates
Beat the Market the Zacks Way: Freshpet, NVIDIA, QuantaSing in Focus
AKYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year?
Acadia Pharmaceuticals (ACAD) Q4 Earnings Lag Estimates
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
Other News for AKYA
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
Akoya Biosciences showcases spatial biology 2.0 solutions at AACR meeting
Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader